Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130) on September 21, 2023. The Pharmaceutical business generated annual sales of KRW 313.9 billion in 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53,800 KRW | -2.89% | -6.76% | -20.06% |
May. 21 | SK Chemicals Implements Safety Evaluation System at Ulsan Plant | MT |
May. 09 | SK Chemicals Swings to Loss in Q1 | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.06% | 717M | |
+5.32% | 40.62B | |
-21.04% | 21.83B | |
-16.29% | 13.09B | |
-13.00% | 9.84B | |
+20.46% | 8.37B | |
+7.95% | 6.73B | |
-30.48% | 5.28B | |
-24.80% | 3.59B | |
-21.48% | 3.43B |
- Stock Market
- Equities
- A285130 Stock
- News SK Chemicals Co.,Ltd
- Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd.